A new Mfn-2 related synthetic peptide promotes vascular smooth muscle cell apoptosis via regulating the mitochondrial apoptotic pathway by inhibiting Akt signaling
Tóm tắt
Restenosis after angioplasty is a major challenge for the treatment of coronary artery diseases. Facilitation of vascular smooth muscle cell (VSMC) apoptosis may be an attractive approach to decrease the incidence of restenosis. We synthesized a 16-amino acid mitofusin-2 (Mfn-2) gene related peptide (MRSP) based on the sequence of the p21ras signature motif, the smallest functional sequence of the Mfn-2 gene with proapoptotic properties in VSMC. We investigated whether MRSP enhanced apoptotic activities to inhibit VSMC accumulation and neointimal hyperplasia in rats with carotid balloon injury. VSMCs were treated with different concentrations of MRSP, the PI3K agonist 740 Y-P and the inhibitor LY294002. Cell apoptosis and related pathway molecules were assessed. MRSP was also given to rats with carotid artery balloon injury. Neointimal hyperplasia and cell apoptotic pathways were detected. In vitro experiments revealed that MRSP treatment significantly increased VSMC apoptosis and induced increases in procaspase-9 cleavage, caspase-3 activation, cytochrome c release from mitochondria to the cytoplasm and the Bax/Bcl-2 ratio but not caspase-8 expression, indicating that the mitochondrial apoptotic cascade was activated by MRSP, which might be attributed to suppression of the PI3K/Akt signaling pathway. We further found that the PI3K agonist 740 Y-P prevented and that the inhibitor LY294002 strengthened the proapoptotic effects of MRSP. MRSP strongly inhibited neointimal hyperplasia and VSMC accumulation, but increased VSMC apoptosis in the vascular wall after balloon injury. Moreover, MRSP substantially enhanced Bax and cleaved caspase-3 expression and decreased Bcl-2 levels in intima, accompanied by decreased levels of phosphorylated Akt and PI3K in vivo. Taken together, the present study showed that MRSP treatment results in a strong proapoptotic effect by activating the mitochondrial apoptotic cascade through suppression of the PI3K/Akt pathway.
Tài liệu tham khảo
Benjamin: Heart Disease and Stroke Statistics-2018 update: a report from the American Heart Association (vol 137, pg e67, 2018). Circulation. 2018; 137: E493–E493.
Levine GN, O’Gara PT. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction (vol 67, pg 1235, 2016). J Am Coll Cardiol. 2016;67:1511–1511.
Lekshmi KM, Che HL, Cho CS, Park IK. Drug- and gene-eluting stents for preventing coronary restenosis. Chonnam Med J. 2017;53:14–27.
Dai Z, Xu G. Restenosis after carotid artery stenting. Vascular. 2017;25:576–86.
Abdelmegid MA, Ahmed TA, Kato M, Ando K, Domei T, Iwabuchi M, Nobuyoshi M. Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: an observational follow-up study of first-time versus repeated restenosis. J Saudi Heart Assoc. 2017;29:76–83.
Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:812–9.
Li P, Zhu N, Yi B, Wang N, Chen M, You X, Zhao X, Solomides CC, Qin Y, Sun J. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res. 2013;113:1117–27.
Matter CM, Chadjichristos CE, Meier P, von Lukowicz T, Lohmann C, Schuler PK, Zhang D, Odermatt B, Hofmann E, Brunner T, et al. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation. 2006;113:1879–87.
Deuse T, Hua XQ, Wang D, Maegdefessel L, Heeren J, Scheja L, Bolanos JP, Rakovic A, Spin JM, Stubbendorff M, et al. Dichloroacetate prevents restenosis in preclinical animal models of vessel injury. Nature. 2014;509:641.
Chandhok G, Lazarou M, Neumann B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol Rev Camb Philos Soc. 2018;93:933–49.
Franco A, Kitsis RN, Fleischer JA, Gavathiotis E, Kornfeld OS, Gong GH, Biris N, Benz A, Qvit N, Donnelly SK, et al. Correcting mitochondrial fusion by manipulating mitofusin conformations. Nature. 2016;540:74.
Chen KH, Guo XM, Ma DL, Guo YH, Li QA, Yang DM, Li PF, Qiu XY, Wen SJ, Xiao RP, Tang JA. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol. 2004;6:872-U878.
Guo XM, Chen KH, Guo YH, Liao H, Tang J, Xiao RP. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res. 2007;101:1113–22.
Zhang GE, Jin HL, Lin XK, Chen C, Liu XS, Zhang Q, Yu JR. Anti-tumor effects of Mfn2 in gastric cancer. Int J Mol Sci. 2013;14:13005–21.
Yan H, Qiu C, Sun W, Gu M, Xiao F, Zou J, Zhang L. Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy. Oncol Rep. 2018;39:1671–81.
Accorsi-Mendonca D, Correa FM, Paiva TB, de Souza HP, Laurindo FR, de Oliveira AM. The balloon catheter induces an increase in contralateral carotid artery reactivity to angiotensin II and phenylephrine. Br J Pharmacol. 2004;142:79–88.
Ali RM, Abdul Kader M, Wan Ahmad WA, Ong TK, Liew HB, Omar AF, Mahmood Zuhdi AS, Nuruddin AA, Schnorr B, Scheller B. Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon. JACC Cardiovasc Interv. 2019;12:558–66.
Kamenz J, Seibold W, Wohlfrom M, Hanke S, Heise N, Lenz C, Hanke H. Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model. Cardiovasc Res. 2000;45:766–76.
Han DK, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267–77.
Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703–11.
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516.
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45:487–98.
Ou LL, Lin SQ, Song B, Liu J, Lai RF, Shao LQ. The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis. Int J Nanomed. 2017;12:6633–46.
Svandova EB, Vesela B, Lesot H, Poliard A, Matalova E. Expression of Fas, FasL, caspase-8 and other factors of the extrinsic apoptotic pathway during the onset of interdigital tissue elimination. Histochem Cell Biol. 2017;147:497–510.
Zheng Q, Wang B, Gao J, Xin N, Wang W, Song X, Shao Y, Zhao C. CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells. J Cell Mol Med. 2018;22:131–40.
Kutuk O, Basaga H. Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis. Apoptosis. 2006;11:1661–75.
Saxena A, McMeekin JD, Thomson DJ. Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens. J Pathol. 2002;196:335–42.
Zhang YY, Qi Y, Zhao Y, Sun HY, Ge JY, Liu ZH. Activin A induces apoptosis of mouse myeloma cells via the mitochondrial pathway. Oncol Lett. 2018;15:2590–4.
Chen XQ, Yang SY, Pan YL, Li X, Ma SL. Mitochondrial pathway-mediated apoptosis is associated with erlotinib-induced cytotoxicity in hepatic cells. Oncol Lett. 2018;15:783–8.
Geng YJ. Molecular signal transduction in vascular cell apoptosis. Cell Res. 2001;11:253–64.
Miyake H, Maeda K, Asai N, Shibata R, Ichimiya H, Isotani-Sakakibara M, Yamamura Y, Kato K, Enomoto A, Takahashi M, Murohara T. The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury. Circ Res. 2011;108:1170–9.
Tucka J, Yu HX, Gray K, Figg N, Maguire J, Lam B, Bennett M, Littlewood T. Akt1 regulates vascular smooth muscle cell apoptosis through FoxO3a and Apaf1 and protects against arterial remodeling and atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34:2421–8.
Annovazzi L, Mellai M, Caldera V, Valente G, Tessitore L, Schiffer D. mTOR, S6 and AKT expression in relation to proliferation and apoptosis/autophagy in glioma. Anticancer Res. 2009;29:3087–94.
Mine T. The role of dehydroepiandrosterone in apoptosis and proliferation and its relation to the phosphatidyl inositol-3-kinase/Akt signaling pathway. J Gastroenterol. 2005;40:553–4.
Zhu LH, Huang L, Zhang X, Zhang P, Zhang SM, Guan H, Zhang Y, Zhu XY, Tian S, Deng K, Li H. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation. Clin Sci (Lond). 2015;129:129–45.
Che HL, Bae IH, Lim KS, Song IT, Lee H, Lee D, Kim WJ, Jeong MH, Ahn Y. Therapeutic effect of Akt1 siRNA nanoparticle eluting coronary stent on suppression of post-angioplasty restenosis. J Biomed Nanotechnol. 2016;12:1211–22.